Related Experiment Video
Updated: Apr 30, 2026

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
Severe malarial anemia is associated with long-term neurocognitive impairment
Paul Bangirana1, Robert O Opoka2, Michael J Boivin3
1Department of Psychiatry, and.
Insights
Severe malaria anemia (SMA) and cerebral malaria (CM) in young children (<5 years) can cause long-term cognitive deficits. CM also impacts attention and memory, while SMA primarily affects cognitive ability, highlighting malaria
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Neuroscience
Background:
- Cerebral malaria (CM) is known to cause neurocognitive impairment in older children.
- No prior prospective studies evaluated neurocognitive outcomes in children under 5 with CM or severe malarial anemia (SMA).
- Severe malarial anemia (SMA) affects millions of children annually and is a significant public health concern.
Purpose of the Study:
- To prospectively assess neurocognitive impairment in children under 5 years old with CM and SMA.
- To compare the long-term neurocognitive outcomes of CM and SMA in young children.
- To identify the specific cognitive domains affected by each severe malaria subtype.
Main Methods:
- Children under 5 with CM (n=80) or SMA (n=86) were recruited in Uganda.
- Neurocognitive assessments (cognitive ability, attention, associative memory) were conducted at 1 week, 6 months, and 12 months post-discharge.
- Outcomes were compared to 61 healthy community children (CC) using mixed linear models, adjusted for covariates.
Main Results:
- At 12 months, children with CM showed significantly lower scores than CC in cognitive ability, attention, and associative memory.
- Children with SMA had significantly lower cognitive ability scores than CC, but not attention or associative memory.
- No significant difference in cognitive ability scores was observed between children with CM and SMA.
Conclusions:
- In children under 5, SMA is linked to long-term cognitive ability impairment.
- CM is associated with additional impairments in attention and associative memory.
- SMA represents a substantial contributor to long-term neurocognitive deficits in sub-Saharan African children.
Background:
Cerebral malaria (CM) is associated with long-term neurocognitive impairment in children ≥5 years of age. No prospective studies to date have assessed neurocognitive impairment in children with CM <5 years of age, or in children with severe malarial anemia (SMA), a form of severe malaria estimated to affect as many as 5 million children annually.
Methods:
Children <5 years of age presenting to Mulago Hospital, Kampala, Uganda, with CM (n = 80) or SMA (n = 86) were assessed for overall cognitive ability, attention, and associative memory 1 week after discharge and 6 and 12 months later. The z scores for each domain were computed based on scores of 61 healthy community children (CC), who were also tested at enrollment and 6 and 12 months later. Groups were compared using mixed linear models, adjusted for age, weight for age, and child's education.
Results:
At 12 months, children with CM had lower adjusted scores than CC in cognitive ability (P < .001), attention (P = .02), and associative memory, (P = .002). Children with SMA had lower scores than CC in cognitive ability (P = .01) but not attention or associative memory. Cognitive ability scores in children with CM and SMA did not differ significantly.
Conclusions:
In children <5 years of age, SMA is associated with long-term impairment in cognitive ability, whereas CM is associated with additional impairment in the areas of attention and associative memory. SMA may be a major contributor to long-term neurocognitive impairment in children in sub-Saharan Africa.
More Related Videos
Related Concept Videos
Hepatic Encephalopathy
Alzheimer Disease l: Introduction
Dementia l: Introduction
Encephalitis l: Introduction
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

